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Similar to people with metabolic syndrome, bottlenose dolphins (Tursiops truncatus) can
have a sustained postprandial hyperglycemia and hyperinsulinemia, dyslipidemia, and fatty
liver disease. A panel of potential postprandial blood-based indicators of insulin resistance
and metabolic syndrome were compared among 34 managed collection dolphins in San
Diego Bay, CA, USA (Group A) and 16 wild, free-ranging dolphins in Sarasota Bay, FL, USA
(Group B). Compared to Group B, Group A had higher insulin (2.1±2.5 and 13±13µIU/ml),
glucose (87±19 and 108±12 mg/dl), and triglycerides (75±28 and 128±45 mg/dl) as
well as higher cholesterol (total, high-density lipoprotein cholesterol, and very low density
lipoprotein cholesterol), iron, transferrin saturation, gamma-glutamyl transpeptidase (GGT),
alanine transaminase, and uric acid. Group A had higher percent unmodified adiponectin.
While Group A dolphins were older, the same blood-based differences remained when con-
trolling for age. There were no differences in body mass index (BMI) between the groups,
and comparisons between Group B and Group A dolphins have consistently demonstrated
lower stress hormones levels in Group A. Group A dolphins with high insulin (greater than
14µIU/ml) had higher glucose, iron, GGT, and BMI compared to Group A dolphins with
lower insulin. These findings support that some dolphin groups may be more susceptible
to insulin resistance compared to others, and primary risk factors are not likely age, BMI,
or stress. Lower high-molecular weight adiponectin has been identified as an indepen-
dent risk factor for type 2 diabetes in humans and may be a target for preventing insulin
resistance in dolphins. Future investigations with these two dolphin populations, including
dietary and feeding differences, may provide valuable insight for preventing and treating
insulin resistance in humans.
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INTRODUCTION
An estimated 347 million people have diabetes globally with an
expected increase to 450 million people in less than 20 years (1, 2).
While type 2 diabetes (T2D) represents 90% of these cases, type
1 diabetes (T1D) is also on the rise, and the search for a cure for
both is urgent (3). Investigating naturally occurring or inciden-
tal metabolic diseases in non-traditional animal populations may
provide valuable insight related to the evolution of, risks for, and
protection against both T1D and T2D in humans (4, 5).
Bottlenose dolphins (Tursiops truncatus), similar to humans
with diabetes, can exhibit a sustained postprandial hyperglycemia
(6, 7). After oral glucose administration, dolphins have a sustained
hyperglycemia paired with a negligible insulin response, similar
to that found in T1D (insulin depletion) (8; Figure 1A). When
dolphins ingest a large fish meal, however, they have a sustained
hyperglycemic and hyperinsulinemic response, matching that of
a person with early T2D (insulin resistance) (8; Figure 1B). Dol-
phins are also susceptible to diseases and conditions associated
with insulin resistance in humans, including fatty liver disease,
urate nephrolithiasis, hemochromatosis, and chronic elevations in
triglycerides, cholesterol, and indicators of inflammation (9–12).
Thus, dolphins may provide new insights for metabolic syndrome,
T1D, and T2D.
Some groups of people are more susceptible to diabetes com-
pared to others (13). In addition to diet and body mass index
(BMI), proposed or known risk factors include genetics, work
schedules, race and ethnicity, and geographic locations (14–17).
Similar to humans, it has been proposed that some dolphin
groups may be at a higher risk of developing metabolic disease
compared to others (18). Hypothesized reasons for metabolic
perturbations in dolphins include older age, overnight fasting,
larger meal sizes with higher purine loads, work schedules that
may vary from their natural circadian rhythm, and genetics (10).
If dolphin populations can be identified that have a relatively
high and low risk of insulin resistance and metabolic syndrome,
comparing these populations may help identify causes, and more
importantly, means of preventing insulin resistance and metabolic
syndrome.
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FIGURE 1 | Insulin levels in a healthy bottlenose dolphin (Tursiops truncatus) following ingestion of (A) 2 g/kg oral glucose and (B) 3–11 g/kg protein
from Spanish mackerel. Data acquired from Patton (8) with permission from the U.S. Navy.
Two groups of dolphins that have been well studied and
compared over the past 40 years are the wild, free-ranging
dolphins in Sarasota Bay, FL, USA, and the U.S. Navy’s
managed collection dolphins in San Diego Bay, CA, USA
(19, 20). Potential blood-based indicators of insulin resis-
tance and metabolic disease in dolphins were compared
among postprandial samples collected from these two dolphin
groups.
MATERIALS AND METHODS
MANAGED AND FREE-RANGING GROUP COMPARISONS
The two populations in this study were managed collection
Atlantic bottlenose dolphins living in San Diego Bay, CA, USA,
cared for by the Navy Marine Mammal Program (MMP) (Group
A, n= 34) and free-ranging Atlantic bottlenose dolphins liv-
ing in Sarasota Bay, FL, USA (Group B, n= 16). The Navy
has housed and cared for dolphins for over 50 years and has
over 1,000 peer-reviewed scientific publications with this pop-
ulation. MMP dolphins live in netted enclosures within San
Diego Bay, many of which have daily open ocean activity ses-
sions. They are fed high-quality, frozen-thawed whole fish diets
consisting of primarily capelin and herring, as well as squid
and mackerel. Diets for individual dolphins are based upon
kilocalories by body weight. MMP dolphins are typically fed
their daily intake over three to eight meals between 0800 and
1500. Before 1990, most MMP dolphins originated from the
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Gulf of Mexico, especially Mississippi Sound. Since the early
1990s, MMP dolphins have been born at the MMP facility in
San Diego Bay. Involvement of MMP dolphins for this study
was approved by the MMP’s Institutional Animal Care and
Use Committee (IACUC) and the Navy Bureau of Medicine
(Protocol # 101-2012). The MMP is accredited by the Associ-
ation for Assessment and Accreditation of Laboratory Animal
Care International.
Sarasota Bay dolphins have been studied since 1970; the long-
term resident population in 2013 spans up to five generations and
includes males up to 50 years old and females up to 63 years old
(20, 21). Descriptions of feeding and activity patterns of Sara-
sota Bay dolphins are provided in Wells et al. (22). Wild dolphin
sampling was approved by the Mote Marine Laboratory IACUC.
Blood sampling from wild dolphins was approved under National
Marine Fisheries Service Scientific Research Permit No. 522-1785
issued to RSW.
The two study populations are both from the Gulf of Mexico
but from different stocks. They are both coastal feeding dolphins
and are taxonomically the same species.
FEEDING AND DIET
Group A was fed one-third of their daily diet in the morning
after their routine overnight fast. Routine diets are based upon
kilocalories per kilogram of body weight and pre-established
caloric needs that vary by age, sex, and activity of each
dolphin. Fish fed were restaurant quality and frozen-thawed
and included primarily capelin (Mallotus villosus) and herring
(Clupea harengus) with or without mackerel (Scomber japoni-
cus) and squid (Loligo opalescens). Mean± SD of calories and
macronutrients in the morning meal were 3,253± 732 kcal,
453± 132 g protein, 184± 43 g fat, and 1± 1 g of carbohy-
drates.
While the timing of the most recent meal prior to each Group
B dolphin’s capture-release was unknown, sonography was used
to assess the presence or absence of stomach contents; Group B
dolphins in the study had contents in their stomachs, supporting
they were in a postprandial state. A summary of diets and feed-
ing behaviors in free-ranging dolphins living in Sarasota Bay is
provided in Wells et al. (22).
SAMPLE COLLECTION
Group A
Following the morning meal, 2 h postprandial blood samples were
drawn (typically near 10:00 a.m.). These dolphins were trained to
present their flukes for blood collection, or blood was collected
from the peduncle while the animal rested on a foam mat out of
water during a routine physical exam.
Group B
Dolphins were captured in shallow water with a seine net
at similar times of the day (20). Following sample collec-
tion, animals were released on site. Blood samples were col-
lected from the fluke while the animal was restrained in the
water or aboard a specially designed veterinary examination
vessel.
Sampling protocol for both study groups
Blood samples were collected using 19–21 gage, 1.5′′ Vacutainer®
needles (Becton Dickinson VACUTAINER Systems, Rutherford,
NJ, USA 07070) or a 21 gage, 0.75′′ butterfly needle attached to a
Vacutainer® Holder.
Blood collected into EDTA was used for complete blood
cell count, 60 min erythrocyte sedimentation rate (ESR), and
glucagon levels. EDTA tubes for glucagon were chilled and 0.04
cc of aprotinin per milliliter of whole blood collected was added
immediately. Blood was centrifuged at 4°C within 30 min and
plasma was transferred to −80°C storage within 1 h. Centrifu-
gation was performed at 3,000 rpm at 4°C for 10 min. Blood
collected into Lithium Heparin was utilized for the lipid panel.
Samples were chilled for 30 min and centrifuged within 2 h. Sam-
ples were sent on cold packs or dry ice via overnight courier
to the reference laboratories. Blood collected into serum sepa-
rator tubes was utilized for serum chemistry, insulin, free fatty
acids, haptoglobin, and adiponectin. Blood for serum chemistry
was left at room temperature and centrifuged within 1 h. Blood
for insulin, free fatty acids, haptoglobin, and adiponectin was
chilled for 30 min, centrifuged within 2 h, and transferred to 80°C
storage.
DIAGNOSTIC TESTS
Total white blood cell (WBC) count was calculated using auto-
mated complete blood count analyses on the Beckman Coulter
LH755 (Beckman Coulter, Brea, CA, USA). Triglycerides and high-
density lipoprotein cholesterol (HDL-C) were directly measured
using the Roche Cobas 8000 system (Roche Molecular Systems,
Pleasanton, CA, USA). Very low density lipoprotein cholesterol
(VLDL-C) was calculated using the following equation: [triglyc-
erides/5]. Low density lipoprotein cholesterol (LDL-C) cholesterol
was calculated as [cholesterol-(VLDL+HDL)]. Fisherbrand Dis-
pette 2®, correlating with the Westergren method, was used to
determine 60 min ESR in-house). Automated complete blood
count analyses and cholesterol measurements were performed by
the Naval Medical Center San Diego.
Serum chemistry analytes included glucose, creatinine, uric
acid, carbon dioxide (CO2), anion gap, globulins, alkaline phos-
phatase (ALP), lactate dehydrogenase (LDH), aspartate amino-
transferase (AST), alanine aminotransferase (ALT), gamma-
glutamyl transpeptidase (GGT), and iron. The above variables
were measured photometrically on the Roche Diagnostics Modu-
lar Analytics P Module clinical chemistry analyzer (Roche Diag-
nostics, Indianapolis, IN, USA) at the Animal Health Diag-
nostic Center at Cornell University. Adiponectin was measured
using parallel reaction monitoring (PRM) as described previ-
ously (23).
Additionally, free and total insulin, free fatty acids, glucagon,
and haptoglobin were analyzed. Both free and total insulin
were measured by ultrafiltration/quantitative chemiluminescent
immunoassay on the Siemens Advia Centaur® Immunoassay sys-
tem (Bayer Diagnostics/Siemens Medical Solutions Diagnostics,
Tarrytown, NY, USA). Free fatty acids were measured spectropho-
tometrically on the Roche Cobas c501 (Roche Diagnostics, Indi-
anapolis, IN, USA). Glucagon was measured by double antibody
radioimmunoassay using the DPC Glucagon Double Anti body
Kit (Siemens, Tarrytown, NY, USA). Insulin, free fatty acids, and
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glucagon were analyzed at ARUP laboratory. Serum haptoglobin
was measured spectrophotometrically at Kansas State Veterinary
Diagnostic Lab (24).
STATISTICAL ANALYSES
Analyses were conducted using SAS Version 9.2 (SAS Incorpo-
rated, Cary, NC, USA). Quantile values for Group A dolphins were
determined for each blood-based variable. Elevated insulin levels
were defined as values greater than the 75th quantile of the study’s
Group A dolphins. Age, sex, BMI [weight (km)/length2 (m)] and
blood values were compared among the following groups: (1)
Group A and Group B, and (2) Group A dolphins with and without
elevated insulin. Sex distribution was compared using a Mantel–
Haenszel Chi-square test; when low numbers were involved, a
Fisher’s exact test was used. Age and blood variable values were
compared using a Wilcoxon rank-sum test. Since Group A dol-
phins were significantly older than Group B dolphins, a covariate
analysis using a general linear model was used, controlling for age,
to compare the two groups. In all analyses, significance was defined
as a P value less than 0.05.
RESULTS
COMPARISONS OF VALUES BETWEEN POPULATIONS
There was no significant difference in sex distribution between the
study groups (percent female, Group A= 44%, Group B= 31%;
P= 0.39). Group A dolphins were older than Group B dolphins
(mean ages= 24.5 and 14 years, respectively; P= 0.003). There
were no differences in BMI when comparing Group A and Group
B (29± 3 and 28± 6, respectively; P= 0.19). Compared to Group
B, Group A dolphins were more likely to have higher glucose, free
and total insulin, triglycerides, total cholesterol, HDL-C, VLDL-
C, iron, transferrin saturation, GGT, ALT, uric acid, and percent
unmodified adiponectin. Group B dolphins were more likely to
have higher free fatty acids, WBC counts, and globulins compared
to Group A dolphins (Table 1).
Higher WBC counts in Group B dolphins were due to higher
eosinophil counts compared to managed collection dolphins
(3,181± 1,561 and 1,050± 539 cells/µl, respectively; P < 0.0001);
neutrophils, monocytes, and lymphocytes were not higher in
Group B compared to Group A dolphins. Group A dolphins were
more likely to have high transferrin saturation (greater than 60%)
compared to Group B dolphins (14/34, 41.2% and 0/16, respec-
tively;P = 0.0003). Group A dolphins were also more likely to have
elevated glucose (greater than 122 mg/dl) (7/34, 20.6% and 0/16,
respectively; P = 0.02).
When controlling for age, Group A dolphins continued to have
higher glucose, free and total insulin, triglycerides, total choles-
terol, HDL-C, VLDL-C, iron, transferrin saturation, GGT, ALT,
uric acid, and percent unmodified adiponectin. Group B dolphins
also still had higher free fatty acids, WBC counts, and globulins
compared to Group A dolphins.
COMPARISONS OF GROUP A DOLPHINS WITH ELEVATED OR
NON-ELEVATED TOTAL INSULIN
Quantile values of the panel variables from Group A dolphins
are provided (Table 2). Eight (23.5%) of 34 dolphins had ele-
vated insulin (greater than 14µIU/ml). There were no significant
differences in sex distribution or age between dolphins with and
Table 1 | Comparisons of potential metabolic, blood-based biomarkers
between a managed collection and a wild, free-ranging bottlenose
dolphin (Tursiops truncatus) population.
Blood variable Mean value±SD
Group A Group B
Managed collection
(n=34)
Free-ranging
(n=16)
Glucose (mg/dl) 108±12* 87±19
Insulin, free (µIU/ml) 10±10* 1.9±2.0
Insulin, total (µIU/ml) 13±13* 2.1±2.5
Glucagon (pg/ml) 170±64 152±93
Free fatty acids (mmol/l) 0.4±0.2 1.4±0.5*
Lipids
Triglycerides (mg/dl) 128±45* 75±28
Cholesterol – total (mg/dl) 217±51* 155±29
HDL-C (mg/dl) 175±33* 122±17
LDL-C (mg/dl) 23±25 19±18
VLDL-C (mg/dl) 26±9* 15±5
Inflammation
WBC (cells/µl×10−3) 7.5±1.6 10.0±1.9*
Globulins (g/dl) 1.8±0.4 2.7±0.4*
ESR (mm/h) 15±12 13±14
Haptoglobin (mg/dl) 581±238 616±268
Total adiponectin 572±3 615±6
Unmodified adiponectin (%) 20±8* 11±5
Iron metabolism and liver
Iron (µg/dl) 178±62* 120±28
Transferrin saturation (%) 59±20* 41±8
GGT (U/l) 30±15* 19±4
AST (U/l) 286±88 246±39
ALT (U/l) 51±20* 36±15
LDH (U/l) 475±86 479±79
Renal function and acid-base
balance
Creatinine (mg/dl) 1.1±0.2 1.3±0.4
CO2 (mEq/l) 29±4 28±3
Uric acid (mg/dl) 0.7±0.3* 0.4±0.3
*Significantly higher (P<0.05).
without elevated insulin (percent female= 2/8, 25% and 13/26,
50%, P= 0.21; mean age= 30.5 and 22.9 years, P= 0.10). Dol-
phins with elevated insulin had higher BMI compared to those
without elevated insulin (31± 3 and 28± 3, P= 0.01). Dolphins
with elevated insulin had higher glucose, iron, and GGT compared
to dolphins without elevated insulin (Table 3).
DISCUSSION
In the current study, common blood-based indicators of insulin
resistance and metabolic syndrome in humans were compared
between two groups of dolphins. Postprandial glucose, insulin,
cholesterol, and triglycerides were higher in the managed dol-
phin group compared to the free-ranging dolphin group. Among
managed dolphins, those with elevated insulin levels (greater than
14µIU/ml) had higher glucose, GGT, iron, and BMI compared to
managed dolphins without elevated insulin. Previous studies have
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Table 2 | About 2 h postprandial values of potential metabolic disease
biomarkers for selected quantiles among 34 managed collection
bottlenose dolphins (Tursiops truncatus).
Blood variable Quantile value
10th 25th 50th 75th 90th
Glucose (mg/dl) 94 99 107 114 124
Insulin, free (µIU/ml) 3 5 8 11 23
Insulin, total (µIU/ml) 4 4 9 14 27
Glucagon (pg/ml) 97 116 175 198 262
Free fatty acids (mmol/l) 0.29 0.32 0.40 0.48 0.55
Lipids
Triglycerides (mg/dl) 80 97 121 151 194
Cholesterol – total (mg/dl) 157 171 207 252 283
HDL-C (mg/dl) 134 147 174 205 218
LDL-C (mg/dl) 3 4 15 37 51
VLDL-C (mg/dl) 16 19 24 30 39
Inflammation
WBC (cells/µl×10−3) 5.9 6.3 7.4 8.4 9.1
Globulins (g/dl) 1.4 1.6 1.8 2.0 2.5
ESR (mm/h) 2 4 6 12 20
Haptoglobin (mg/dl) 3.4 6.6 12 22 32
Total adiponectin 286 393 525 688 948
Unmodified adiponectin % 11 14 19 24 32
Iron metabolism and liver
Iron (µg/dl) 106 135 174 215 264
Transferrin saturation (%) 35 44 59 72 92
GGT (U/l) 19 22 26 32 42
Renal function and acid-base
balance
Creatinine (mg/dl) 0.8 1.0 1.1 1.3 1.4
CO2 (mEq/l) 26 27 28 30 38
Anion gap 12 14 15 16 17
Uric acid (mg/dl) 0.4 0.5 0.6 0.8 1.0
demonstrated that approximately 39 and 67% of this study’s man-
aged population have subclinical fatty liver disease and hemochro-
matosis at death (10). Metabolic syndrome in humans has a variety
of definitions, but most include high postprandial glucose, hyper-
insulinemia, hypertriglyceridemia, and non-alcoholic fatty liver
disease (NAFLD) (25–27). As such, this study supports that some
groups of dolphins may be more susceptible to insulin resistance,
metabolic syndrome, and their complications compared to others.
Free-ranging dolphins from Sarasota Bay, FL, USA, and man-
aged dolphins at the Navy MMP in San Diego, CA, USA included
in this study have been well studied for over 40 years (19, 20).
Many Sarasota Bay dolphins demonstrate strong fidelity to their
location and group, and health is tracked throughout each dol-
phin’s lifetime using routine population surveys and capture-
release health assessments. The MMP cares for a population of
approximately 80 dolphins that receive top-level care from a team
of marine mammal veterinarians, are trained to provide routine,
voluntary blood samples, and are part of a vigilant preventive
health program.
Assessed differences between these two groups of dolphins have
included age, BMI, and stress hormones. Annual survival rates
Table 3 | Comparisons of selected blood variable values among
dolphins with and without elevated 2 h postprandial total insulin
levels (>14µIU/ml).
Blood variable Mean value±SD
Elevated total
insulin (n=8)
Non-elevated total
insulin (n=26)
Glucose (mg/dl) 116±12* 106±12
Insulin, free (µIU/ml) 24±12* 6.1±2.4
Insulin, total (µIU/ml) 31±16* 7.7±3.6
Glucagon (pg/ml) 147±46 178±67
Free fatty acids (mmol/l) 0.4±0.1 0.5±0.2
Lipids
Triglycerides (mg/dl) 148±59 123±39
Cholesterol – total (mg/dl) 211±24 219±58
HDL-C (mg/dl) 185±24 172±35
LDL-C (mg/dl) 11±6 25±26
VLDL-C (mg/dl) 30±12 25±8
Inflammation
WBC (cells/µl×10−3) 7.6±2.3 7.4±1.3
Globulins (g/dl) 1.7±0.5 1.9±0.4
ESR (mm/h) 11±9 9±9
Haptoglobin (mg/dl) 12±12 16±12
Total adiponectin 594±237 576±244
Unmodified adiponectin (%) 16±7 22±8
Iron metabolism and liver
Iron (µg/dl) 213±32* 167±66
Transferrin saturation (%) 68±15 56±21
GGT (U/l) 34±9* 29±16
AST (U/l) 282±68 287±94
ALT (U/l) 53±22 51±19
LDH (U/l) 498±78 468±89
Renal function and
acid-base balance
Creatinine (mg/dl) 1.2±0.2 1.1±0.2
CO2 (mEq/l) 29±3.8 28±4.0
Uric acid (mg/dl) 0.6±0.2 0.7±0.3
*Significantly higher (P<0.05).
and mean age at death of Sarasota Bay and MMP dolphins are
0.97 and 0.99; and 19.9 and 36 years old, respectively (22, 28,
29). While MMP dolphins in this study were older than Sara-
sota Bay dolphins, differences in blood values between these two
groups remained after controlling for age. With regard to BMI,
there was no difference between the two study groups. Previous
comparisons have demonstrated that Sarasota Bay dolphins have
significantly higher levels of stress hormones cortisol and aldos-
terone compared to MMP dolphins (30). This comparison was
again confirmed with current data, in which the mean cortisol
level in Sarasota Bay dolphins during the study was 2.99µg/dl;
the mean level recently measured among 29 MMP dolphins was
less than 0.43µg/dl (unpublished data, personal communication
with Houser). Thus, increased free fatty acid levels identified in
Sarasota Bay dolphins were possibly due to relatively higher stress;
both cortisol and free fatty acid levels can increase during stress
(31). This is not surprising, given that free-ranging dolphins are
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captured and released, while MMP dolphins are trained to volun-
tarily and routinely present their flukes for blood sampling. Thus,
old age, high BMI, and stress are not supported as leading causes
of insulin resistance and metabolic syndrome in dolphins.
Diet is an important risk factor for insulin resistance and meta-
bolic syndrome in humans (32). Sarasota Bay dolphins eat a wide
variety of live fish and squid, while MMP dolphins are fed high-
quality frozen-thawed fish, primarily capelin and herring (22).
Nutritional content comparisons of fish commonly ingested by
Sarasota Bay versus MMP dolphins (pigfish, pinfish, and mullet
versus capelin and herring) suggested that Sarasota Bay fish may
have higher calcium and vitamin D; lower potassium, sodium,
zinc, linoleic acid, and docosahexaenoic acid; and differences in
polyunsaturated fatty acids compared to fish eaten by managed
dolphins (33). Interestingly, fish diets have been found to be both
beneficial and detrimental for people with type 2 diabetes (34, 35).
Further studies in dolphins and their diets may provide insight into
which fish nutrients are protective against or risk factors for T2D
in people.
In humans, exercise increases glycemic control and protects
against the development of T2D (36). Sarasota Bay dolphins fol-
low a consistent circadian pattern of increased activity during the
day. They remain active throughout the day and rest only 2% of
that time (22). They also routinely dive during the day and night
and travel during the day and night at rates around 1.4 m/s (37).
MMP dolphins are also actively swimming during the day and
night in their large Bay-based enclosures, including daily open
ocean sessions in San Diego Bay for many MMP dolphins. While
similar BMI between the two groups indicates that lack of activ-
ity and obesity are not the drivers for their metabolic differences,
further studies are needed to better compare energy expenditure
between these two groups.
Several compelling parallels with human diabetes, insulin resis-
tance, and metabolic syndrome were identified in this study
with dolphins. Components of insulin resistance-associated dys-
lipidemia in humans include over production of VLDL-C and
increased triglyceride levels (38). These changes, paired with mod-
erate liver-specific insulin resistance, can lead to hepatic steatosis
(39). In the current study, MMP dolphins had higher triglyc-
erides, total cholesterol, HDL-C, and VLDL-C. Fatty liver disease
in dolphins has been previously associated with chronic hyper-
glycemia, and findings from this study further support that dol-
phins and humans with metabolic syndrome may have parallel
susceptibilities to dyslipidemias (10).
In the current study, paired indicators of insulin resistance with
increased liver enzymes may increase the relevance of the dol-
phin as a model for metabolic syndrome and insulin resistance for
humans. GGT and ALT were higher when comparing managed
collection dolphins with the free-ranging dolphins; additionally,
within the managed collection study group, GGT was higher
among those with elevated insulin compared to those without ele-
vated insulin. Increased ALT and GGT are indicators of NAFLD
and its progression to non-alcoholic steatohepatitis (NASH) (40).
The association between GGT and fatty liver disease in dolphins
could be confirmed if liver biopsies were available for histologic
examination.
Adiponectin is a protein primarily secreted by adipocytes in
mammals, and it has a role in increasing insulin sensitivity and
decreasing inflammation (41, 42). In the current study, managed
dolphins had higher percent unmodified adiponectin compared
to free-ranging dolphins. It is known that the degree of modifica-
tion of adiponectin is what results in adiponectin oligomerization
into mid- and high-molecular weight multimers (43, 44). While
the components of modified adiponectin could not be confirmed,
results from this study suggest that mid to high-molecular weight
adiponectin levels were lower in managed dolphins. In humans,
lower high-molecular weight adiponectin is related to insulin resis-
tance and a higher risk for T2D (45, 46). Furthermore, lower
adiponectin concentration is an independent risk factor for the
development of and progression to T2D (47, 48). While further
work is needed to confirm that dolphins from the managed col-
lection in this study had lower levels of high-molecular weight
adiponectin, this early finding provides a targeted area for future
research.
Insulin resistance in humans has been associated with iron
overload (49, 50). In the current study, 41% of managed collec-
tion dolphins tested had a transferrin saturation greater than 60%
while none of the free-ranging dolphins had similarly high lev-
els. Previous studies have demonstrated that this study’s and other
managed collection dolphins have higher iron and transferrin sat-
uration compared to free-ranging dolphin populations living in
the Indian River Lagoon, FL, USA and Charleston, SC, USA (18).
Hemochromatosis, or iron overload, has been well documented
in MMP dolphins (9, 10). Dolphins with hemochromatosis have
higher 2 h postprandial insulin levels compared to healthy con-
trols, and approximately 67% of MMP dolphins appear to have
hemochromatosis at time of death (7, 10). While none of the
managed collection dolphins in the current study had clinically
high iron levels (greater than 300µg/dl), this study continues to
support that elevated insulin is associated with increasing iron
in dolphins. The underlying mechanism of this association in
humans has not yet been fully elucidated, and better understand-
ing of insulin and iron metabolism could benefit both dolphins
and humans.
In summary, two groups of dolphins were identified that appear
to have higher and lower risks of developing insulin resistance and
metabolic syndrome. This study and the supporting literature did
not support that age, body mass, or stress were primary drivers
of insulin resistance or metabolic syndrome in dolphins. Under-
standing risk and protective factors for metabolic syndrome in
these two dolphin populations may lead to immediate and trans-
lational means of preventing and treating insulin resistance and
T2D in humans.
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